(RTTNews) - Friday, Glaukos Corporation (GKOS) announced positive topline results from a Phase 4 study evaluating iDose TR in combination with cataract surgery in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
(RTTNews) - Avient Corp. (AVNT), a manufacturer of colorants, additives and polymers, announced Friday that its Board of Directors has appointed Mike Frank as President and Chief Executive Officer, effective immediately. Frank succeeds Ashish Khandpur, who has stepped down from h
Key PointsAMD, already past a $1 trillion market cap, needs about 70% more growth to pass Broadcom's $1.7 trillion, a target its OpenAI deal makes realistic.
Key PointsThe VanEck Semiconductor ETF's annualized 30.3% return over the past five years shows what is possible for semiconductor stocks, but Sandisk and MaxLinear can outshine the ETF over the next five years.
(RTTNews) - Friday, Teva Pharmaceuticals (TEVA) announced that the U.S. FDA has approved WELTRUZA (olanzapine) extended-release injectable suspension for adults with schizophrenia.
(RTTNews) - Friday, Eli Lilly (LLY) reported new exploratory Phase 3b data from the TOGETHER-PsO study evaluating Taltz (ixekizumab) and Zepbound (tirzepatide) in adults with psoriasis and obesity or overweight.
(RTTNews) - The U.K. stock market's benchmark index FTSE 100 climbed higher Friday morning, supported by gains in mining and technology sectors. Lower crude oil prices and bond yields amid easing tensions about U.S.-Iran conflict lifted sentiment.
(RTTNews) - France's equity benchmark CAC 40 was modestly higher a little past noon on Friday as stocks gained some ground in positive territory amid easing geopolitical tensions after U.S. President Donald Trump said the U.S. will not attack Iran before the midterm elections nex
In recent trading, shares of Campbell's Company (Symbol: CPB) have crossed above the average analyst 12-month target price of $19.35, changing hands for $19.37/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v
In recent trading, shares of APA Corp (Symbol: APA) have crossed above the average analyst 12-month target price of $45.22, changing hands for $45.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, o
In recent trading, shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $110.45, changing hands for $119.47/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v
In recent trading, shares of LXP Industrial Trust (Symbol: LXP) have crossed above the average analyst 12-month target price of $61.00, changing hands for $61.01/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on